Agomab is translating a deep expertise in growth factor biology to pioneer and develop novel treatments that aim to resolve fibrosis, repair tissue structure and restore organ function. Combining new scientific insights with robust drug development and a long-term corporate vision, we are building a broad clinical pipeline of differentiated programs with disease modifying potential in severe organ failure and fibrotic diseases.
Company Details
- Employees
- 68
- Founded
- -
- Address
- Antwerp, Be
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- agomab.com
- Keywords
- in growth factor biology to pioneer and develop novel treatments that aim to resolve fibrosis.
- HQ
- Antwerp
Agomab Questions
Agomab's website is agomab.com
Agomab's LinkedIn profile is https://be.linkedin.com/company/agomab
Agomab has
68 employees.
View email and phone details for 68
employees at Agomab.
Agomab's industry is
Biotechnology Research
Agomab's top competitors are
Confo Therapeutics,
Flamingo Therapeutics,
Ablynx,
Etherna,
Pantera,
Exevir,
Aphea.bio,
Biotalys,
Argenx,
Galapagos.
Agomab's categories are Biotechnology Research
Agomab's founding year is 2017
